haemodialysis centres. One is located in Nottingham, UK, the other in Tassin, France. This comparison clearly demonstrates that patient survival is much better in the French dialysis unit than in the dialysis unit in England. After careful analysis of all relevant risk factors such as age and comorbidity, the authors conclude that the main identifiable factor, which could explain this difference in survival, is a marked difference in blood pressure among the patients from each unit. In Nottingham, most patients had chronic hypertension; in Tassin, which uses the drug free dry weight method of BP control [8] , BP of almost all their patients was in the low normal range.
This important comparison of survival results between Nottingham and Tassin also is of great interest because of the type of patients that did not show a difference in survival. These groups included diabetics and patients who began dialysis with severe cardiovascular co-morbidity. One would not expect control of BP to significantly prolong life in these groups because they already have advanced atherosclerosis and do not survive long enough to give BP control a chance to stabilize or perhaps reverse this condition. In the Belding H. Scribner born January 18, 1921.
Framingham study [9] , it took a minimum of 10 years for the benefits of normalizing BP to show an effect In the April 1999 issue of Nephrology Dialysis on patient survival. Thus, conclusions from papers like Transplantation, there is an article which summarizes that of Zager et al. [10] are misleading. These authors, the report of the US task force convened to study the based on a 2.5-year study, concluded that: 'Establishing epidemic of cardiovascular disease in the haemodialysis optimal BP targets in patients will require a multipopulation [1]. This task force, composed of prestigi-centre randomized controlled clinical trial that includes ous experts, collectively made a report on what to do serial electrocardiograms, 48 h APBM's and informaabout the growing epidemic of cardiovascular disease tion on antihypertensive medications'. Such a concluin the haemodialysis population. On page 832, in the sion is unwarranted when one considers the mountain all important 'treatment of hypertension' section, this of evidence that supports the proposition that longsummary article contains the following statement: 'All term control of hypertension uniformly helps to preclasses of anti-hypertensive agents are effective with vent the development of atherosclerosis. the exception of diuretics'. If that statement is true, However, in some dialysis patients with a life expecthow come greater than 65% of the world's haemodia-ancy of less than 5 years due to age and/or comorbidity, lysis patients are hypertensive [2-6 ]?
aggressive treatment to try and control BP may represIn this same April 1999 issue, beginning on page ent a distraction and perhaps even be harmful. This 919 is a report of a study by Innes et al. [7] . This idea is supported by a recent study of Port et al. [11] study compares the mortality between two top quality and editorial comments by Salem [12] . In Port's study, a low (<110 mmHg) pre-dialysis systolic BP was a [15] (iii) Primitive tribes [17] could be explained by the fact, also emphasized by must have been at the low end of normal in order for his rice diet to control essential hypertension. In other Foley [13] , that hypotension may be a marker of underlying severe heart disease. Other or complement-words, Kempner's patients were at what I define as dry weight. This idea assumes that the only way the ary possibilities are that the low BP and early mortality may be linked to malnutrition, or inadequate dialysis. rice/fruit diet could cure hypertension was by decreasing the size of the ECV. What beneficial role the high In chronically ill patients such as these, concentrating on providing a high dose of dialysis with the minimum potassium intake in the rice/fruit diet had is not clear.
Kempner's patients ate a diet remarkably similar in set at a URR of 0.7 would be most beneficial. At the same time using good clinical judgement can easily sodium content to that of some primitive tribes as described by Fries [17] . Thus, they fit in the same solve this problem of the management of BP in haemodialysis patients with a short life expectancy such as category in Table 1 . These tribes have no hypertension and their BP reaches a peak in the mid-twenty age diabetics who have rapidly progressive or far advanced cardiovascular diseases. The expensive study called for range and declines thereafter as they grow older.
Populations in this category remain at dry weight by Zager [10] is not needed.
If antihypertensive medications are indeed effective throughout their lives. Finally, as shown in Table 1 , normotensive haemoin treating hypertension in haemodialysis patients, then why did they not work in Nottingham or in two out dialysis patients at dry weight have a time averaged ECV which is similar in size as that of primitive tribes of three patients over the world? The fact of the matter is that antihypertensive medications are not only who ingest a very low sodium diet or patients with essential hypertension that have been successfully poorly effective in haemodialysis patients but must be discontinued before the dry weight method can be used treated by the rice/fruit diet. In the case of dialysis patients, this low normal level of ECV is maintained to control blood pressure [8] .
In order to explain my position, I have constructed by the powerful tool, ultrafiltration, which if properly used along with moderate dietary sodium restriction is Table 1 . Column one in this table is a hypothesis that divides normal extracellular volume (ECV ) into three the only proven method of controlling BP in the haemodialysis population. In my view, the answer to sub-groups. This hypothesis will need confirmation if, and when, ECV measurements, which are more precise the question posed in the title is 'no'. than those currently available, are devised to study this problem of the proposed relationship between small sustained changes in average ECV and BP. The [16 ] . I hypothesize that the ECV of these patients
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